Qube Research & Technologies LTD Syros Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.69 - $1.21 $36,959 - $64,813
53,565 New
53,565 $52,000
Q3 2021

Nov 12, 2021
SELL
$4.08 - $5.66 $321,397 - $445,860
-78,774 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$5.01 - $7.48 $211,842 - $316,284
42,284 Added 115.88%
78,774 $429,000
Q1 2021

May 14, 2021
BUY
$7.19 - $14.95 $262,363 - $545,525
36,490 New
36,490 $273,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email